Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Large-scale testing (Phase 3)Study completedNCT00004179What this trial is testingCombination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's LymphomaWho this might be right forLymphoma European Organisation for Research and Treatment of Cancer - EORTC 475
Testing effectiveness (Phase 2)Study completedNCT00387959What this trial is testingChemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma Memorial Sloan Kettering Cancer Center 17
Not applicableStudy completedNCT00248547What this trial is testingAprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell TransplantWho this might be right forCancer OHSU Knight Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT00732498What this trial is testingRituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHLWho this might be right forLymphoma University of Arizona 28
Not applicableStudy completedNCT00416312What this trial is testingIodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Large-scale testing (Phase 3)Study completedNCT00075946What this trial is testingRituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's LymphomaWho this might be right forLymphoma Eastern Cooperative Oncology Group 545
Early research (Phase 1)Study completedNCT00244946What this trial is testingCombination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Barbara Ann Karmanos Cancer Institute 15
Not applicableStudy completedNCT00408681What this trial is testingLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more Fred Hutchinson Cancer Center 20
Early research (Phase 1)Study completedNCT00641381What this trial is testingCarmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated LymphomaWho this might be right forLymphoma City of Hope Medical Center 25
Large-scale testing (Phase 3)Study completedNCT00053053What this trial is testingComparison of Nutritional Supplements in Preventing Weight Loss in Patients With CancerWho this might be right forCachexiaLymphomaLymphoproliferative Disorder+1 more Radiation Therapy Oncology Group 472
Testing effectiveness (Phase 2)Ended earlyNCT00301795What this trial is testingRituximab and Oblimersen in Treating Patients With Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's LymphomaWho this might be right forStage III Grade 1 Follicular LymphomaStage III Grade 2 Follicular LymphomaStage III Grade 3 Follicular Lymphoma+3 more National Cancer Institute (NCI) 52
Not applicableEnded earlyNCT01076270What this trial is testingPlerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+80 more Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)WithdrawnNCT00004039What this trial is testingCombination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV LymphomaWho this might be right forLymphoma Hoag Memorial Hospital Presbyterian
Testing effectiveness (Phase 2)UnknownNCT00008307What this trial is testingCombination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic DisordersWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Herbert Irving Comprehensive Cancer Center 52
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Early research (Phase 1)Study completedNCT00352443What this trial is testingS0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific SWOG Cancer Research Network 66
Early research (Phase 1)Study completedNCT00443976What this trial is testingAurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkins LymphomaUnspecified Adult Solid Tumor, Protocol Specific NCIC Clinical Trials Group 35
Early research (Phase 1)Study completedNCT00004260What this trial is testingInterleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Mayo Clinic
Not applicableStudy completedNCT00856388What this trial is testingFludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure DisordersWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+97 more Roswell Park Cancer Institute 62